Oncology guidelines suggest using the Khorana score to select ambulatory cancer patients receiving chemotherapy for primary venous thromboembolism (VTE) prevention, but its performance in different cancers remains uncertain.

The Khorana score for prediction of venous thromboembolism in cancer patients: An individual patient data meta-analysis

Ageno, Walter
Membro del Collaboration Group
;
2020-01-01

Abstract

Oncology guidelines suggest using the Khorana score to select ambulatory cancer patients receiving chemotherapy for primary venous thromboembolism (VTE) prevention, but its performance in different cancers remains uncertain.
2020
Khorana score; cancer; heparin; individual participant data meta-analysis; thromboprophylaxis; venous thromboembolism
van Es, Nick; Ventresca, Matthew; Di Nisio, Marcello; Zhou, Qi; Noble, Simon; Crowther, Mark; Briel, Matthias; Garcia, David; Lyman, Gary H; Macbeth, Fergus; Griffiths, Gareth; Iorio, Alfonso; Mbuagbaw, Lawrence; Neumann, Ignacio; Brozek, Jan; Guyatt, Gordon; Streiff, Michael B; Baldeh, Tejan; Florez, Ivan D; Gurunlu Alma, Ozlem; Agnelli, Giancarlo; Ageno, Walter; Marcucci, Maura; Bozas, George; Zulian, Gilbert; Maraveyas, Anthony; Lebeau, Bernard; Lecumberri, Ramon; Sideras, Kostandinos; Loprinzi, Charles; Mcbane, Robert; Pelzer, Uwe; Riess, Hanno; Solh, Ziad; Perry, James; Kahale, Lara A; Bossuyt, Patrick M; Klerk, Clara; Büller, Harry R; Akl, Elie A; Schünemann, Holger J
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11383/2097759
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 26
  • Scopus 59
  • ???jsp.display-item.citation.isi??? 56
social impact